News
Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have prolonged OS. Pancreatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback